US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist
  • 60.075
  • +5.935+10.96%
Trading Nov 11 09:40 ET
121.84BMarket Cap-16780P/E (TTM)

Bristol-Myers Squibb Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bristol-Myers Squibb Q3 2024 Earnings Date

Currency：USDOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
11.25B
11.89B
+646.47M
Beat Est.
+2.55%
+8.44%
+5.75%
EPS
0.65
0.60
-0.05
Miss Est.
-29.92%
-35.48%
-7.93%
Analyst Rating
Hold

Nov 7, 2024

Bristol-Myers Squibb Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
Apr 24, 2025 2025/Q1 -- / 11.673B --
Feb 6, 2025 2024/Q4 -- / 11.541B --
Oct 31, 2024 2024/Q3 11.892B / 11.246B --
Jul 26, 2024 2024/Q2 12.201B / 11.522B --
Apr 25, 2024 2024/Q1 11.865B / 11.451B --
DatePeriodRevenue/EstimateEarnings Call
Apr 24, 20252025/Q1-- / 11.673B--
Feb 6, 20252024/Q4-- / 11.541B--
Oct 31, 20242024/Q311.892B / 11.246B--
Jul 26, 20242024/Q212.201B / 11.522B--
Apr 25, 20242024/Q111.865B / 11.451B--

Unlock Free Earnings Estimates

Bristol-Myers Squibb Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Oct 31 23:46

  • 10-Q: Q2 2024 Earnings Report

    Jul 27 00:08

  • 10-Q: Q1 2024 Earnings Report

    Apr 26 00:40

  • Bristol-Myers Squibb | 10-K: FY2023 Annual Report

    Feb 14 01:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 7, 2024

    Hold

    • Buy

      18.75%

    • Hold

      68.75%

    • Sell

      12.50%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Cancer Research
    Cancer Research
    Intraday+1.41%